Stockreport

Sherwin-Williams: Why Some See Downward Potential [Seeking Alpha]

AKZO NOBEL N V S/ADR  (AKZOY) 
US:NASDAQ Investor Relations: akzonobel.com/for-investors/shares/adr
PDF SHW's premium valuation—trading at over 30x P/E—creates an unattractive risk/reward profile, especially versus peers like AkzoNobel with lower multiples and higher yiel [Read more]